Insulin resistance and renal disease.

In non-diabetic patients with (primary) kidney diseases a syndrome of insulin resistance can be diagnosed even before the onset of impaired renal function and uremia. It is presenting with hyperinsulinemia, glucose intolerance, hyperglycemia and dyslipidemia. As a result, patients with kidney diseases own the same metabolic cardiovascular risk factors as patient with the classic metabolic syndrome. Thus, this renal insulin resistance syndrome may not only contribute to the excessive cardiovascular risk of patients with kidney diseases, but may also help to explain why even a minor impairment of renal function is a significant and independent cardiovascular risk factor in the general population.

[1]  G. Chertow,et al.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.

[2]  J. Schelling,et al.  The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? , 2004, Journal of the American Society of Nephrology : JASN.

[3]  Samy I McFarlane,et al.  The relationship between hyperinsulinemia, hypertension and progressive renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[4]  S. Bagby Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? , 2004, Journal of the American Society of Nephrology : JASN.

[5]  R. Schall,et al.  Old antihypertensives and new diabetes , 2004, Journal of hypertension.

[6]  M. Woodward,et al.  Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. , 2004, International journal of epidemiology.

[7]  B. Goldstein,et al.  Adiponectin: A novel adipokine linking adipocytes and vascular function. , 2004, The Journal of clinical endocrinology and metabolism.

[8]  K. Iseki,et al.  Body mass index and the risk of development of end-stage renal disease in a screened cohort. , 2004, Kidney international.

[9]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[10]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[11]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[12]  M. Stumvoll,et al.  Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[13]  M. Reilly,et al.  The Metabolic Syndrome: More Than the Sum of Its Parts? , 2003, Circulation.

[14]  E. Lonn,et al.  Cardiovascular risk in patients with mild renal insufficiency. , 2003, Kidney international. Supplement.

[15]  P. Whelton,et al.  Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. , 2003, Journal of the American Society of Nephrology : JASN.

[16]  H. Koyama,et al.  Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[17]  D. Matthews,et al.  The assessment of insulin resistance in man , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[18]  E. Ritz,et al.  Altered temporal organization of plasma insulin oscillations in chronic renal failure. , 2002, The Journal of clinical endocrinology and metabolism.

[19]  T. Saruta,et al.  Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. , 2000, Clinical nephrology.

[20]  S. Spaia,et al.  Effect of Short-Term rHuEPO Treatment on Insulin Resistance in Haemodialysis Patients , 2000, Nephron.

[21]  M. Stumvoll,et al.  Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.

[22]  M. Stumvoll,et al.  Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. , 1998, American journal of physiology. Endocrinology and metabolism.

[23]  R. Wilkinson,et al.  Insulin resistance in adult polycystic kidney disease. , 1997, Kidney international.

[24]  M. Stumvoll,et al.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. , 1995, The Journal of clinical investigation.

[25]  S. Strandgaard,et al.  Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity , 1995, Diabetologia.

[26]  W. Sheu,et al.  Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. , 1994, The Quarterly journal of medicine.

[27]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[28]  R. Mak,et al.  Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. , 1992, Kidney international.

[29]  W. Guder,et al.  Renal substrate metabolism. , 1986, Physiological reviews.

[30]  M. Ishii,et al.  Elevated plasma catecholamines in hypertensives with primary glomerular diseases. , 1983, Hypertension.

[31]  R. DeFronzo,et al.  Insulin resistance in uremia. , 1981, The Journal of clinical investigation.

[32]  H. Bergman,et al.  THE RELATIONSHIP OF KIDNEY FUNCTION TO THE GLUCOSE UTILIZATION OF THE EXTRA ABDOMINAL TISSUES , 1938 .

[33]  V. Mazzaferro,et al.  Nonhepatic glucose production in humans. , 2004, American journal of physiology. Endocrinology and metabolism.

[34]  S. Kihara,et al.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[35]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[36]  P. Garlick,et al.  Insulin regulation of renal glucose metabolism in humans. , 1999, American journal of physiology. Endocrinology and metabolism.

[37]  G. Pacini,et al.  Intravenous calcitriol normalizes insulin sensitivity in uremic patients. , 1995, Kidney international.

[38]  R. DeFronzo,et al.  Glucose and insulin metabolism in uremia. , 1992, Nephron.